Medybiz Pharma Profile
Key Indicators
- Authorised Capital ₹ 15.48 Cr
as on 16-11-2024
- Paid Up Capital ₹ 10.49 Cr
as on 16-11-2024
- Company Age 15 Year, 27 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 54.70 Cr
as on 16-11-2024
- Satisfied Charges ₹ 2.00 Cr
as on 16-11-2024
- Revenue 15.30%
(FY 2023)
- Profit -36.84%
(FY 2023)
- Ebitda -177.41%
(FY 2023)
- Net Worth 52.24%
(FY 2023)
- Total Assets 7.75%
(FY 2023)
About Medybiz Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.48 Cr and a paid-up capital of Rs 10.49 Cr.
The company currently has active open charges totaling ₹54.70 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Medybiz Pharma Private Limited India is Aditi Jain as COMPANY SECRETARY. Vaibhav Tewari and Ramasubramani Ganesan serve as directors at the Company.
- CIN/LLPIN
U24117KA2009PTC051603
- Company No.
051603
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Medybiz Pharma Private Limited offer?
Medybiz Pharma Private Limited offers a wide range of products and services, including Mineral Supplement, Calcium Tablet, Call Centre & Customer Care Services, Customer Care BPO Services, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Vitamin Tablets & Capsules, Vitamin C Tablets & Capsules, Cough Syrup, ISO & Quality Management Consultants.
Who are the key members and board of directors at Medybiz Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditi Jain  | Company Secretary | 02-Nov-2023 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vaibhav Tewari | Director | 29-Feb-2016 | Current |
| Ramasubramani Ganesan | Director | 25-Sep-2024 | Current |
Financial Performance and Corporate Structure Insights of Medybiz Pharma.
Medybiz Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.3% increase. The company also saw a substantial fall in profitability, with a 36.84% decrease in profit. The company's net worth Soared by an impressive increase of 52.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medybiz Pharma?
In 2023, Medybiz Pharma had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 10 Apr 2023 | ₹16.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 10 Apr 2023 | ₹38.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 10 Apr 2023 | ₹7.00 M | Open |
How Many Employees Work at Medybiz Pharma?
Medybiz Pharma has a workforce of 102 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medybiz Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medybiz Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
